Expression in Escherichia coli and purification of the functional feline granulocyte colony-stimulating factor

Vet Immunol Immunopathol. 2002 Dec;90(3-4):169-77. doi: 10.1016/s0165-2427(02)00259-3.

Abstract

Feline granulocyte colony-stimulating factor (G-CSF) with an N-terminal histidine hexamer tag was expressed as inclusion bodies in E. coli. The G-CSF solubilized in 6 M guanidine solution was absorbed onto a Ni-NTA column and, after washing with decreasing concentrations of guanidine, eluted with imidazole in a soluble and apparently pure form. The activity of the recombinant feline G-CSF was 3 x 10(6)U/mg protein, as assayed by its stimulatory effect on NFS-60 cell proliferation. When a low level of purified feline G-CSF was administered once a day for two successive days to cats, the number of neutrophil increased 4-fold while the levels of other blood cell types remained virtually unchanged. Daily administration of G-CSF for a total of 11 days led to a more than 10-fold increase in neutrophils, an 8-fold increase in the number of monocytes and 2-fold increase in lymphocytes. No severe side effects or antibody production was observed in cats after administration of G-CSF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cats
  • Cell Division / drug effects
  • Dose-Response Relationship, Drug
  • Escherichia coli / genetics*
  • Gene Expression
  • Granulocyte Colony-Stimulating Factor / biosynthesis
  • Granulocyte Colony-Stimulating Factor / genetics
  • Granulocyte Colony-Stimulating Factor / isolation & purification*
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Granulocytes / drug effects
  • Leukocyte Count / veterinary
  • Macrophages / drug effects
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Recombinant Proteins
  • Time Factors

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor